| Filed On | Filing |
|---|---|
| 13 Oct 2026 | SCHEDULE 13G |
| 29 Sep 2026 |
8-K: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities
At the effective time of the Merger (the “Effective Time”), each outstanding share of Mantle capital stock (other than shares held by Mantle as treasury shares, shares held by Lexeo or Merger Sub, and Dissenting Shares) was converted int... |
| 28 Sep 2026 |
Form 4: Bhalla Narinder Pal, Chief Medical Officer
Received 2,714 shares as a grant or award ($9.71K) · Granted 54,750 Stock Option (right to buy) |
| 28 Sep 2026 |
Form 4: Tamayo Louis Edward, Chief Financial Officer
Granted 54,750 Stock Option (right to buy) |
| 28 Sep 2026 |
Form 4: Otero Jose Manuel, Chief Operating Officer
Received 2,110 shares as a grant or award ($5.58K) · Granted 54,750 Stock Option (right to buy) |
| 28 Sep 2026 |
Form 4: Townsend Richard Nolan, Director
Received 2,306 shares as a grant or award ($6.1K) · Granted 145,500 Stock Option (right to buy) |
| 22 Sep 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. |
| 19 Aug 2026 |
Form 4: Tamayo Louis Edward, Chief Financial Officer
Sold 4,117 shares ($20.2K) |
| 19 Aug 2026 |
Form 4: Townsend Richard Nolan, Director
Sold 3,345 shares ($16.6K) |
| 19 Aug 2026 |
Form 4: Otero Jose Manuel, Chief Operating Officer
Sold 1,304 shares ($6.46K) |
| 18 Aug 2026 | 144 |
| 18 Aug 2026 | 144 |
| 18 Aug 2026 | 144 |
| 14 Aug 2026 | SCHEDULE 13G |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 | 8-K: Results of Operations and Financial Condition; Other Events |
| 12 Aug 2026 | 10-Q |
| 07 Aug 2026 | SCHEDULE 13G |
Loading...